Board-Certified GI Specialists
Phoenix & Gilbert Locations
Advanced Endoscopy Technology
Same-Week Appointments
Barrett’s esophagus is a serious digestive condition caused by long-term acid reflux that permanently changes the lining of your esophagus, and without proper monitoring, it can progress to esophageal cancer. At Digestive Institute of Arizona, our board-certified gastroenterologists provide comprehensive Barrett’s esophagus care for patients across Phoenix, Gilbert, and the greater Maricopa County area, from initial diagnosis through advanced endoscopic treatment.
Whether you’ve been newly diagnosed or have been managing this condition for years, we build personalized treatment plans based on your specific dysplasia grade, health history, and lifestyle. Our two conveniently located offices, Phoenix and Gilbert, AZ, make specialist care accessible without long wait times.
📞 Call us or Book Your Appointment Online, Same-week appointments available.
Barrett’s esophagus occurs when stomach acid repeatedly damages the esophageal lining, causing normal cells to be replaced by intestine-like tissue. It is directly linked to GERD (Gastroesophageal Reflux Disease) and affects approximately 10–15% of people with long-term acid reflux. While not cancer itself, Barrett’s esophagus requires consistent monitoring, the only way to catch any cellular changes before they progress.
Is Barrett’s esophagus cancer?
No. It is a precancerous condition that must be closely monitored by a qualified gastroenterologist to prevent progression.
One of the most challenging aspects of Barrett’s esophagus is that many patients experience no noticeable symptoms, especially in the early stages. The condition is frequently discovered during an upper endoscopy performed for another reason, which is exactly why screenings are so important for anyone with a history of chronic acid reflux.
When symptoms do appear, they overlap significantly with GERD and may include:
Important: Having heartburn does NOT confirm Barrett’s esophagus, and having no symptoms does NOT rule it out. The only reliable way to diagnose this condition is through endoscopy with biopsy.
At Digestive Institute of Arizona, we offer the full spectrum of Barrett’s esophagus treatment, from conservative GERD management to advanced endoscopic ablation procedures. Your individualized treatment plan is based on your dysplasia grade, segment length, overall health, and personal goals.
Regular endoscopy helps track patients with Barrett’s esophagus for changes occurring within esophageal cells. During an upper endoscopy, a thin, flexible camera tube is passed through your mouth to inspect the esophagus and stomach. Tissue samples (biopsies) collected during this procedure are used to evaluate dysplasia presence and grading, a precursor deviation from normal cell structures that indicate cancerous development.
Destroying the abnormal esophageal tissue in patients with severe (advanced precancerous changes) can be done using endoscopic ablation techniques. These are minimally invasive procedures that are performed during an upper endoscopy. Some of the commonest ones include:
Surgery is reserved for patients with high-grade dysplasia that cannot be managed endoscopically or for confirmed esophageal cancer. The most common procedure is an esophagectomy, surgical removal of the diseased esophageal segment, with reconstruction connecting the remaining esophagus to the stomach. Our team maintains collaborative relationships with thoracic surgeons across the Phoenix metro area to ensure seamless, coordinated surgical referrals when necessary.
Patients across the Phoenix metropolitan area – including Chandler, Scottsdale, Tempe, Mesa, and Gilbert – choose Digestive Institute of Arizona for Barrett’s esophagus care because of our commitment to specialized, compassionate gastroenterology in a patient-first environment.
What sets our Barrett’s esophagus program apart:
Board-certified gastroenterologists with subspecialty expertise in esophageal disease and advanced endoscopic procedures.
Two convenient Arizona locations, Phoenix and Gilbert, with same-week appointments available
Advanced endoscopy technology, including high-definition scopes and narrow-band imaging, for the most accurate Barrett's surveillance
Complete treatment spectrum under one roof - from GERD management to RFA, cryotherapy, PDT, and surgical coordination
Individualized care plans - every treatment plan is tailored to your dysplasia grade, health history, and lifestyle goals
Collaborative, coordinated care - we work closely with your primary care physician, oncologist, or surgeon as needed
Accessible office hours - Monday through Friday, 8:00 AM – 4:00 PM
Insurance-friendly practice - contact us to verify your coverage before your visit
Yes, Barrett’s esophagus has a documented hereditary component. First-degree relatives (parents, siblings, or children) of patients diagnosed with Barrett’s esophagus or esophageal adenocarcinoma carry a higher-than-average risk. If this condition runs in your family, we strongly recommend a proactive discussion about screening during your first consultation at our Phoenix or Gilbert clinic.
Barrett’s esophagus cannot be diagnosed based on symptoms alone. The gold standard is an upper endoscopy (EGD – Esophagogastroduodenoscopy) paired with tissue biopsy.
During this procedure, one of our experienced gastroenterologists passes a thin, flexible camera through your mouth to visually examine the esophagus and stomach lining. We use high-definition endoscopes with advanced imaging technology, including narrow-band imaging (NBI), to detect subtle mucosal changes that standard white-light endoscopy may miss. Biopsy samples are sent to a pathology lab to confirm the presence of intestinal metaplasia and assess dysplasia.
No. Barrett’s esophagus is a precancerous condition, not cancer. It increases your risk of esophageal adenocarcinoma, but the annual progression rate for patients without dysplasia is only about 0.1–0.3%. With regular surveillance and proper treatment, the vast majority of Barrett’s patients never develop cancer.
Barrett’s esophagus cannot be naturally reversed, but abnormal tissue can be fully eliminated through endoscopic treatments such as radiofrequency ablation (RFA) and cryotherapy. After successful ablation, normal squamous tissue regenerates. However, ongoing surveillance is still recommended after treatment, as Barrett’s can recur.
GERD is the underlying acid reflux condition. Barrett’s esophagus is a complication of long-standing GERD in which the esophageal lining permanently changes. Not everyone with GERD develops Barrett’s esophagus — but chronic, uncontrolled GERD is the single biggest risk factor.